Amkor Technology has delivered one of its strongest weekly runs of the year, yet short sellers are not retreating — a tension that defines the setup heading into the July 27 earnings print.
The stock closed at $86.55 on Tuesday, up 22% on the week and 23% over the past month. That move has carried the price well above the mean analyst price target of $75.50 — a target set back in late April, when the most recent cluster of upgrades arrived after Q1 results. At those levels, the stock is running roughly 15% through consensus, which changes the valuation math materially. The PE multiple has expanded to 38.4x, up more than 8 points over the past 30 days, and price-to-book has pushed to 4.1x. The stock is no longer cheap by any of the measures that anchored the bull case earlier in the year.
Short interest has continued to grind higher even as the stock rallied — and that divergence is the most interesting signal this week. Since the last note on June 10, shorts have added another 2.5%, bringing the position to 8.69 million shares, or 3.5% of the free float. That is up nearly 18% on the week and roughly 20% over the past month, extending the rebuild documented previously. The borrow market remains extraordinarily accommodative: availability is running at 2,940% — nearly 30 shares available for every one already lent out — and cost to borrow has actually fallen sharply, down 39% over the week to just 0.28%. Shorts are adding into a strong rally with essentially no friction. That is a deliberate choice, not a forced one.
Options traders are leaning the other way. The put/call ratio has slipped to 0.78, running almost 1.7 standard deviations below its 20-day average of 0.83 — one of the more call-heavy readings of recent weeks. That tilt toward calls fits the price action: the rally has drawn in buyers who want upside exposure, not protection. The contrast with the short interest build is sharp. One set of participants is pressing the momentum trade via calls; another is quietly adding to a short position through the move. Both camps are cheap to express their view, which makes the eventual resolution at earnings more consequential.
The Street view adds another layer of complexity. The most recent analyst actions — from Goldman Sachs, Morgan Stanley, B. Riley, and Needham, all filed on April 28 following Q1 results — lifted targets across the board but left ratings unmoved. Goldman kept Neutral with a $65 target. Morgan Stanley held Equal-Weight at $69. Only Needham carries a Buy, with a $90 target that the stock has now approached. With the price at $86.55 and the consensus target at $75.50, the implied return from here is negative on a consensus basis — a structural headwind for fresh institutional buyers. The bull case rests on Arizona facility ramp-up delivering high-margin output that drives earnings upgrades; the bear case centres on the 1-2 percentage point margin drag from that same facility, combined with CHIPS Act funding uncertainty and heavy Asia revenue exposure.
Earnings history reinforces the caution. The last three prints each produced a negative next-day move: down 8.6%, down 1.9%, and down 4.0%. The five-day windows were also negative in two of those three cases. The July 27 event is therefore one the market has repeatedly sold in the recent past — a pattern worth watching as the stock heads into it trading well through analyst targets and with shorts still building.
See the live data behind this article on ORTEX.
Open AMKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
